Frailty reshapes nalbuphine dosing for elderly postoperative pain relief

A new study has examined how frailty affects the correct dosage of nalbuphine for pain relief in elderly patients after surgery. Researchers focused on those undergoing elective laparoscopic gastrointestinal procedures, where managing postoperative pain remains a key challenge. The findings highlight the need for tailored dosing based on individual frailty levels.

The research involved elderly patients scheduled for laparoscopic gastrointestinal surgery, grouped by their frailty status using recognised assessment tools. A modified Dixon-based sequential allocation method was used to determine the median effective dose (ED50) of nalbuphine for each group. This approach helped identify precise dosing requirements for frail versus non-frail patients.

Results showed clear differences in how much nalbuphine was needed for effective pain relief between the two groups. Frail patients required adjusted doses compared to their non-frail counterparts, reinforcing the importance of frailty assessments in pain management planning. Nalbuphine, a mixed opioid agonist-antagonist, was chosen for its suitability in elderly care due to its distinct pharmacological properties.

The study's structured methodology and clinical focus contribute to advancements in geriatric anaesthesiology. By demonstrating the value of frailty-stratified dosing, the research supports wider adoption of personalised analgesic protocols in postoperative care.

The findings confirm that frailty significantly influences the effective dose of nalbuphine in elderly surgical patients. Clinicians are now urged to consider frailty assessments when planning pain relief strategies. This approach aims to improve safety and efficacy in postoperative analgesia for older adults.